Payment overview · 2025
General Payments
$69.95
6 reported records · 3 companies
Healthcare provider profile · identity verified
Brandy M. Shelton
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · MADISONVILLE, KY · NPI 1225650542
Verified facts
What the public records show
CMS Open Payments records show Brandy M. Shelton received $69.95 in general payments during 2025 across 6 reported records.
Phathom Pharmaceuticals, Inc. accounted for 52.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
Amgen Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PROLIA as an associated drug or biological on 20867 records involving 11744 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Prolia by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $36.74 | 52.5% | 4 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $18.93 | 27.1% | 1 | 2025 |
| Novartis Pharmaceuticals Corporation | Unresolved — no canonical attribution shown | $14.28 | 20.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $69.95 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $36.74 | 4 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $18.93 | 1 | 2025 |
Source payment records
|
|||||
| LEQVIO Normalized: leqvio |
Drug | Novartis Pharmaceuticals Corporation | $14.28 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Amgen Inc. Exact reporting entity; no affiliate inference |
2025 | PROLIA open payments reported associated product |
CMS Open Payments — General Payments 20867 supporting records · 11744 recipient NPIs · example record 1226874448 |
Prolia · 2024 Exact normalized brand match · 1 Part D row |
17 | 11 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 490 | 114 |
| Atorvastatin Calcium | Atorvastatin Calcium | 289 | 82 |
| Ozempic | Semaglutide | 262 | 58 |
| Lisinopril | Lisinopril | 236 | 71 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 228 | 70 |
| Losartan Potassium | Losartan Potassium | 227 | 57 |
| Jardiance | Empagliflozin | 193 | 42 |
| Pantoprazole Sodium | Pantoprazole Sodium | 187 | 48 |
| Amlodipine Besylate | Amlodipine Besylate | 186 | 47 |
| Mounjaro | Tirzepatide | 186 | 25 |
| Farxiga | Dapagliflozin Propanediol | 167 | 34 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 162 | 48 |
| Metformin Hcl | Metformin Hcl | 158 | 38 |
| Omeprazole | Omeprazole | 149 | 42 |
| Simvastatin | Simvastatin | 147 | 41 |
| Hydrochlorothiazide | Hydrochlorothiazide | 138 | 38 |
| Buspirone Hcl | Buspirone Hcl | 135 | 36 |
| Duloxetine Hcl | Duloxetine Hcl | 133 | 30 |
| Metformin Hcl Er | Metformin Hcl | 127 | 36 |
| Pravastatin Sodium | Pravastatin Sodium | 117 | 24 |
| Synthroid | Levothyroxine Sodium | 108 | 26 |
| Potassium Chloride | Potassium Chloride | 107 | 27 |
| Furosemide | Furosemide | 105 | 32 |
| Allopurinol | Allopurinol | 104 | 28 |
| Metoprolol Tartrate | Metoprolol Tartrate | 102 | 24 |
| Ezetimibe | Ezetimibe | 94 | 29 |
| Metoprolol Succinate | Metoprolol Succinate | 88 | 23 |
| Trazodone Hcl | Trazodone Hcl | 83 | 25 |
| Fluticasone Propionate | Fluticasone Propionate | 82 | 43 |
| Alendronate Sodium | Alendronate Sodium | 80 | 24 |
| Repatha Sureclick | Evolocumab | 79 | 21 |
| Gabapentin | Gabapentin | 74 | 24 |
| Montelukast Sodium | Montelukast Sodium | 74 | 20 |
| Alprazolam | Alprazolam | 70 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 69 | 55 |
| Nateglinide | Nateglinide | 63 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 61 | 17 |
| Trulicity | Dulaglutide | 60 | 13 |
| Carvedilol | Carvedilol | 59 | 18 |
| Escitalopram Oxalate | Escitalopram Oxalate | 54 | 16 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 51 | 21 |
| Mupirocin | Mupirocin | 50 | 39 |
| Zolpidem Tartrate | Zolpidem Tartrate | 50 | 11 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 49 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 49 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 48 | 16 |
| Hydralazine Hcl | Hydralazine Hcl | 47 | 17 |
| Tamsulosin Hcl | Tamsulosin Hcl | 46 | 16 |
| Doxepin Hcl | Doxepin Hcl | 43 | suppressed |
| Omnipod 5 Dexg7g6 Pods (Gen 5) | Insulin Pump Cart,auto,bt,g6/7 | 43 | suppressed |
| Famotidine | Famotidine | 41 | 12 |
| Novolog Flexpen | Insulin Aspart | 41 | 13 |
| Celecoxib | Celecoxib | 40 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 39 | 17 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 38 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 38 | suppressed |
| Atenolol | Atenolol | 37 | 11 |
| Estradiol | Estradiol | 36 | suppressed |
| Nystatin | Nystatin | 36 | 22 |
| Testosterone Cypionate | Testosterone Cypionate | 36 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 35 | 14 |
| Lovastatin | Lovastatin | 35 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 35 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 34 | 12 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 34 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 30 | 13 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 29 | suppressed |
| Fenofibrate | Fenofibrate | 29 | suppressed |
| Naproxen | Naproxen | 29 | suppressed |
| Eliquis | Apixaban | 28 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 27 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 27 | 22 |
| Propranolol Hcl | Propranolol Hcl | 27 | suppressed |
| Pregabalin | Pregabalin | 26 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 26 | suppressed |
| Baqsimi | Glucagon | 24 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 24 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 24 | suppressed |
| Lansoprazole | Lansoprazole | 24 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 24 | suppressed |
| Myrbetriq | Mirabegron | 24 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 24 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 24 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 23 | suppressed |
| Vascepa | Icosapent Ethyl | 23 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 23 | suppressed |
| Diazepam | Diazepam | 22 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 22 | suppressed |
| Humalog | Insulin Lispro | 22 | suppressed |
| Insulin Lispro | Insulin Lispro | 22 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 22 | suppressed |
| Azithromycin | Azithromycin | 21 | 20 |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 21 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 21 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 21 | suppressed |
| Spironolactone | Spironolactone | 21 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 21 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 20 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Mirtazapine | Mirtazapine | 20 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 19 | suppressed |
| Lamotrigine | Lamotrigine | 19 | suppressed |
| Linzess | Linaclotide | 19 | suppressed |
| Novolog | Insulin Aspart | 19 | suppressed |
| Bupropion Xl | Bupropion Hcl | 18 | suppressed |
| Prednisone | Prednisone | 18 | 12 |
| Ramipril | Ramipril | 18 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Fluconazole | Fluconazole | 17 | suppressed |
| Januvia | Sitagliptin Phosphate | 17 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 17 | suppressed |
| Prolia | Denosumab | 17 | 11 |
| Tizanidine Hcl | Tizanidine Hcl | 17 | suppressed |
| Cephalexin | Cephalexin | 16 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 15 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 15 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 15 | suppressed |
| Lyumjev Kwikpen U-100 | Insulin Lispro-Aabc | 15 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Sucralfate | Sucralfate | 15 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 14 | 13 |
| Meloxicam | Meloxicam | 14 | suppressed |
| Clonazepam | Clonazepam | 13 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 13 | suppressed |
| Gemtesa | Vibegron | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Irbesartan | Irbesartan | 13 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 13 | suppressed |
| Lorazepam | Lorazepam | 13 | suppressed |
| Lyumjev | Insulin Lispro-Aabc | 13 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 12 | suppressed |
| Gvoke Hypopen 2-Pack | Glucagon | 12 | 11 |
| Methylprednisolone | Methylprednisolone | 12 | suppressed |
| Rybelsus | Semaglutide | 12 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 12 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 11 | suppressed |
| Cycloset | Bromocriptine Mesylate | 11 | suppressed |
| Dutasteride | Dutasteride | 11 | suppressed |
| Finasteride | Finasteride | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $69.95 · 6 records | Phathom Pharmaceuticals, Inc. | EVENITY, LEQVIO, VOQUEZNA | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Amgen Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error